Potentially Inappropriate Screening Colonoscopy in Medicare Patients Variation by Physician and Geographic Region

JAMA Internal Medicine (Impact Factor: 13.12). 03/2013; 173(7):1-9. DOI: 10.1001/jamainternmed.2013.2912
Source: PubMed


IMPORTANCE Inappropriate use of colonoscopy involves unnecessary risk for older patients and consumes resources that could be used more effectively. OBJECTIVES To determine the frequency of potentially inappropriate colonoscopy in Medicare beneficiaries in Texas and to examine variation among physicians and across geographic regions. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study used 100% Medicare claims data for Texas and a 5% sample from the United States from 2000 through 2009. We identified Medicare beneficiaries aged 70 years or older who underwent a colonoscopy from October 1, 2008, through September 30, 2009. MAIN OUTCOME MEASURES Colonoscopies were classified as screening in the absence of a diagnosis suggesting an indication for the procedure. Screening colonoscopy was considered potentially inappropriate on the basis of patient age or occurrence too soon after colonoscopy with negative findings. The percentage of patients undergoing potentially inappropriate screening colonoscopy was estimated for each colonoscopist and hospital service area. RESULTS A large percentage of colonoscopies performed in older adults were potentially inappropriate: 23.4% for the overall Texas cohort and 9.9%, 38.8%, and 24.9%, respectively, in patients aged 70 to 75, 76 to 85, or 86 years or older. There was considerable variation across the 797 colonoscopists in the percentages of colonoscopies performed that were potentially inappropriate. In a multilevel model including patient sex, race or ethnicity, number of comorbid conditions, educational level, and urban or rural residence, 73 colonoscopists had percentages significantly above the mean (23.9%), ranging from 28.7% to 45.5%, and 119 had percentages significantly below the mean (23.9%), ranging from 6.7% to 18.6%. The colonoscopists with percentages significantly above the mean were more likely to be surgeons, graduates of US medical schools, medical school graduates before 1990, and higher-volume colonoscopists than those with percentages significantly below the mean. Colonoscopist rankings were fairly stable over time (2006-2007 vs 2008-2009). There was also geographic variation across Texas and the United States, with percentages ranging from 13.3% to 34.9% in Texas and from 19.5% to 30.5% across the United States. CONCLUSIONS AND RELEVANCE Many colonoscopies performed in older adults may be inappropriate. The likelihood of undergoing potentially inappropriate colonoscopy depends in part on where patients live and what physician they see.

Download full-text


Available from: James S Goodwin, Jul 01, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hintergrund Das American Board of Internal Medicine (ABIM) startete 2011 die Choosing Wisely Initiative (CWI). Material und Methoden Mit dieser Initiative werden fachspezifische Top-5-Listen mit der Zielsetzung erstellt, diagnostische und therapeutische Maßnahmen, die den Patienten nicht nützen, sondern potenziell sogar schaden, zu reduzieren und damit die Kosten im Gesundheitswesen zu senken. Die von der American Geriatrics Society und der American Medical Director Association 2013 veröffentlichten Vorschläge werden diskutiert. Ergebnisse Der Prozess, so einfach er zunächst erscheint, wirft dennoch vielfältige Fragen auf. Eine Übertragung auf Deutschland scheint grundsätzlich möglich, sollte aber weitere Aspekte des Gesundheitswesen und seiner Organisation berücksichtigen.
    No preview · Article · Jan 2013 · Zeitschrift für Gerontologie + Geriatrie
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Life expectancy is an important consideration when assessing appropriateness of preventive programs for older individuals. Most studies on this subject have used age cutoffs as a proxy for life expectancy. We analyzed patterns of utilization of screening colonoscopy in Medicare enrollees using estimated life expectancy. We used a 5% random national sample of Medicare claims data to identify average-risk patients who underwent screening colonoscopies from 2008 through 2010. Colonoscopies were considered to be screening colonoscopies in the absence of diagnoses for non-screening indications, based on either colonoscopies or any claims in the preceding 3 months. We estimated life expectancies using a model that combined age, sex, and comorbidity. Among patients who underwent screening colonoscopies, we calculated the percentage of those with life expectancies <10 y. Among the 57,597 Medicare beneficiaries 66 y old or older who received at least 1 screening colonoscopy, 24.8% had an estimated life expectancy of <10 y. There was a significant positive association between total Medicare per capita costs in hospital referral regions and the proportion of patients with limited life expectancies (<10 y) at the time of screening colonoscopy (R=0.25; P<.001, Pearson correlation test). In a multivariable analysis, men were substantially more likely than women to have limited life expectancy at the time of screening colonoscopy (odds ratio=2.25; 95% confidence interval, 2.16-2.34). Nearly 25% of Medicare beneficiaries, especially men, had life expectancies <10 y at the time of screening colonoscopies. Life expectancy should therefore be incorporated in decision making for preventive services.
    Full-text · Article · Aug 2013 · Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The national cost of cancer care is projected to reach $173 billion by 2020, increasing from $125 billion in 2010. This steep upward cost trajectory has placed enormous an financial burden on patients, their families, and society as a whole and raised major concern about the ability of the health care system to provide and sustain high-quality cancer care. To better understand the cost drivers of cancer care and explore approaches that will mitigate the problem, the National Cancer Policy Forum of the Institute of Medicine held a workshop entitled "Delivering Affordable Cancer Care in the 21st Century" in October 2012. Workshop participants included bioethicists, health economists, primary care physicians, and medical, surgical, and radiation oncologists, from both academic and community settings. All speakers expressed a sense of urgency about the affordability of cancer care resulting from the future demographic trend as well as the high cost of emerging cancer therapies and rapid diffusion of new technologies in the absence to evidence indicating improved outcomes for patients. This article is our summary of presentations at the workshop that highlighted the overuse and underuse of screening, treatments, and technologies throughout the cancer care continuum in oncology practice in the United States.
    Full-text · Article · Oct 2013 · Journal of Clinical Oncology
Show more